SPOTLIGHT: Debate heats up over drug importation

On the surface, importing lower-cost prescription drugs from overseas sounds like an idea anyone would like--after all, it has the potential to save massive amounts of money. But as with other aspects of the healthcare reform debate, things are more complicated than they look. The idea of allowing such imports is opposed strongly by the pharmaceutical industry, and their resistance is creating yet another quagmire in the legislative process. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.